CBFB/MYH11
The SensiQuant Direct CBFB/MYH11 products are designed for the QUALITATIVE detection and QUANTITATIVE measurement of INV-16A, INV-16D, and INV-16E transcripts in cases of Acute Myeloid Leukemia (AML).
The product line includes:
- SensiQuant Direct Master Mix
- SensiQuant Standard (from 10^5 to 10 copies)
- SensiQuant Positive Control
CBFB/MYH11 t(15;17), variant INV-16A
CBFB/MYH11 t(15;17), variant INV-16D
CBFB/MYH11 t(15;17), variant INV-16E
- QUALITATIVE Analysis = SensiQuant Direct Master Mix + SensiQuant Positive Control
- QUANTITATIVE Analysis = SensiQuant Direct Master Mix + SensiQuant Standard
- One-Step Technology
- Single plasmid of CBFB/MYH11 and ABL
- Linear Range (1,000,000 to 10 copies CBFB/MYH11)
- Consistent Thermal Cycle across the SensiQuant DIRECT product line
- High ABL Copy Numbers (enhanced method sensitivity)
- High specificity, sensitivity, and accuracy
- High reproducibility (intra- and inter-assay)
- Fast and easy to use
- High stability
- CE/IVD marking